BioLargo, Inc. announced that it expects to receive $0.815 million in funding
November 16, 2023
Share
BioLargo, Inc. announced that it will receive $815,000 in funding on November 17, 2023. The company will issue common shares in the transaction. The minimum investment accepted from any outside investor is $25,000.
The company will issue securities pursuant to exemption provided under Regulation D.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental segment enagaged in selling odor and volatile organic control products and services. Clyra Medical segment develops and sells medical products based on its technologies. BLEST segment provides professional engineering services on a time and materials basis for outside clients and supports its internal operations as needed. Its Canada segment is the main hub of its scientists researching and developing its technologies. Its BETI segment is enagaged in developing its proprietary battery technology. BEST segment manages the sales and distribution of its water treatment products and related services.